No Data
shanghai titan scientific co.,ltd. (688133.SH): Currently, we are not involved in the research, production, and sales of monkeypox products.
Shanghai Titan Scientific Co.,Ltd. (688133.SH) stated on the investor interaction platform on September 6 that the company mainly provides scientific research reagents, specialty chemicals, research instruments and consumables, laboratory construction and research information services. Some of the raw materials needed for the production of reagent kits are provided by the company, but the company is currently not involved in the research, production, and sales of monkeypox products.
Shareholders of Shanghai Titan Scientific Co., Ltd. (688133.SH) plan to reduce their shareholding by a total of no more than 2%.
Shanghai Titan Scientific Co., Ltd. (688133.SH) announced that, due to the business development needs of its shareholders, Tianjin Chuangfeng and Ningbo Dongkai...
Express News | Shanghai Titan Scientific Co., Ltd.: Shareholders plan to reduce their shareholding by no more than 2%.
Express News | shanghai titan scientific co.,ltd. and other established laboratory system engineering companies
Shanghai Titan Scientific Co.,Ltd. (688133) 2024 Semi-Annual Report Review: Actively promoting the development of independent brand products. The company's performance in Q2 2024 improved compared to the previous quarter.
Event: On August 29, 2024, Shanghai Titan Scientific Co.,Ltd. released its 2024 interim report: In the first half of 2024, revenue reached 1.396 billion yuan, a year-on-year increase of 5.13%; achieving a net income attributable to the parent company of 0.05.
Titan Technology 2024 Semi-Annual Report
No Data
No Data